|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 14/47 | (2006.01) |
| C07K 16/18 | (2006.01) | ||
| C12N 15/12 | (2006.01) | ||
| A61K 38/00 | (2006.01) |
| (11) | Number of the document | 2291395 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09745570.3 |
| Date of filing the European patent application | 2009-05-14 | |
| (97) | Date of publication of the European application | 2011-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2015-08-12 |
| (46) | Date of publication of the claims translation | 2015-12-28 |
| (86) | Number | PCT/EP2009/003447 |
| Date | 2009-05-14 |
| (87) | Number | WO 2009/138236 |
| Date | 2009-11-19 |
| (30) | Number | Date | Country code |
| 08008944 | 2008-05-14 | EP | |
| 53182 P | 2008-05-14 | US |
| (72) |
STEVANOVIC, Stefan, DE
GOUTTEFANGES, Cécile, DE
RAMMENSEE, Hans-Georg, DE
WEINSCHENK, Toni, DE
LEWANDROWSKI, Peter, DE
|
| (73) |
Immatics Biotechnologies GmbH,
Paul-Ehrlich-Strasse 15, 72076 Tübingen,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Nauji ir galingi MHC II klasės peptidai, gauti iš survivino |
| NOVEL AND POWERFUL MHC-CLASS II PEPTIDES DERIVED FROM SURVIVIN |
| Payment date | Validity (years) | Amount | |
| 2020-04-30 | 12 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-05-14 |